A Reichert Selected Research

Tretinoin (Retinoic Acid)

8/2000

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Reichert Research Topics

Disease

3	Leukemia 03/2001 - 09/2000
2	Philadelphia Chromosome 04/2001 - 01/2000
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2001 - 03/2001
2	Lymphoma (Lymphomas) 03/2001 - 09/2000
2	Residual Neoplasm 08/2000 - 01/2000
1	Out-of-Hospital Cardiac Arrest 04/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2008
1	Pancytopenia 03/2007
1	Congenital amegakaryocytic thrombocytopenia 03/2007
1	Hematologic Neoplasms (Hematological Malignancy) 04/2001
1	Acute Promyelocytic Leukemia 08/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

2	Oncogene Proteins (Oncogene Protein)IBA 04/2001 - 02/2001
1	Cytochromes c (Cytochrome c)IBA 10/2008
1	Apoptosis Inducing FactorIBA 10/2008
1	PhosphotyrosineIBA 04/2001
1	Pharmaceutical PreparationsIBA 03/2001
1	TransferasesIBA 03/2001
1	lonafarnib (SCH 66336)IBA 03/2001
1	Proteins (Proteins, Gene)FDA Link 02/2001
1	bcr-abl Fusion ProteinsIBA 09/2000
1	DNA (Deoxyribonucleic Acid)IBA 09/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2000
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 08/2000
1	Interferon-alpha (Interferon Alfa)IBA 01/2000

Therapy/Procedure

2	Therapeutics 08/2000 - 01/2000
1	Airway Management 04/2020
1	Transplantation 03/2007